These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 20144240)
1. A dual function TAR Decoy serves as an anti-HIV siRNA delivery vehicle. Unwalla HJ; Rossi JJ Virol J; 2010 Feb; 7():33. PubMed ID: 20144240 [TBL] [Abstract][Full Text] [Related]
2. Lentiviral-mediated delivery of combined HIV-1 decoy TAR and Vif siRNA as a single RNA molecule that cleaves to inhibit HIV-1 in transduced cells. Barnor JS; Miyano-Kurosaki N; Yamaguchi K; Abumi Y; Ishikawa K; Yamamoto N Nucleosides Nucleotides Nucleic Acids; 2005; 24(5-7):431-4. PubMed ID: 16247965 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of HIV-1 replication by long-term treatment with a chimeric RNA containing shRNA and TAR decoy RNA. Barnor JS; Habu Y; Yamamoto N; Miyano-Kurosaki N; Ishikawa K; Yamamoto N; Takaku H Antiviral Res; 2009 Aug; 83(2):156-64. PubMed ID: 19397929 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of HIV-LTR gene expression by oligonucleotides targeted to the TAR element. Vickers T; Baker BF; Cook PD; Zounes M; Buckheit RW; Germany J; Ecker DJ Nucleic Acids Res; 1991 Jun; 19(12):3359-68. PubMed ID: 2062653 [TBL] [Abstract][Full Text] [Related]
5. Attenuating HIV Tat/TAR-mediated protein expression by exploring the side chain length of positively charged residues. Wu CH; Chen YP; Liu SL; Chien FC; Mou CY; Cheng RP Org Biomol Chem; 2015 Dec; 13(45):11096-104. PubMed ID: 26399751 [TBL] [Abstract][Full Text] [Related]
6. Aromatic polyamidines inhibiting the Tat-induced HIV-1 transcription recognize structured TAR-RNA. Mischiati C; Jeang KT; Feriotto G; Breda L; Borgatti M; Bianchi N; Gambari R Antisense Nucleic Acid Drug Dev; 2001 Aug; 11(4):209-17. PubMed ID: 11572598 [TBL] [Abstract][Full Text] [Related]
7. HIV-1 RRE RNA acts as an RNA silencing suppressor by competing with TRBP-bound siRNAs. Daniels SM; Sinck L; Ward NJ; Melendez-Peña CE; Scarborough RJ; Azar I; Rance E; Daher A; Pang KM; Rossi JJ; Gatignol A RNA Biol; 2015; 12(2):123-35. PubMed ID: 25668122 [TBL] [Abstract][Full Text] [Related]
8. HIV-1 TAR element is processed by Dicer to yield a viral micro-RNA involved in chromatin remodeling of the viral LTR. Klase Z; Kale P; Winograd R; Gupta MV; Heydarian M; Berro R; McCaffrey T; Kashanchi F BMC Mol Biol; 2007 Jul; 8():63. PubMed ID: 17663774 [TBL] [Abstract][Full Text] [Related]
9. Discoveries of Tat-TAR interaction inhibitors for HIV-1. Yang M Curr Drug Targets Infect Disord; 2005 Dec; 5(4):433-44. PubMed ID: 16535863 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of HIV-1 infection by lentiviral vectors expressing Pol III-promoted anti-HIV RNAs. Li MJ; Bauer G; Michienzi A; Yee JK; Lee NS; Kim J; Li S; Castanotto D; Zaia J; Rossi JJ Mol Ther; 2003 Aug; 8(2):196-206. PubMed ID: 12907142 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of Tat-mediated transactivation of HIV-1 LTR transcription by polyamide nucleic acid targeted to TAR hairpin element. Mayhood T; Kaushik N; Pandey PK; Kashanchi F; Deng L; Pandey VN Biochemistry; 2000 Sep; 39(38):11532-9. PubMed ID: 10995220 [TBL] [Abstract][Full Text] [Related]
12. Effects on RNAi of the tight structure, sequence and position of the targeted region. Yoshinari K; Miyagishi M; Taira K Nucleic Acids Res; 2004; 32(2):691-9. PubMed ID: 14762201 [TBL] [Abstract][Full Text] [Related]
13. A simple assay system for examination of the inhibitory potential in vivo of decoy RNAs, ribozymes and other drugs by measuring the Tat-mediated transcription of a fusion gene composed of the long terminal repeat of HIV-1 and a gene for luciferase. Koseki S; Ohkawa J; Yamamoto R; Takebe Y; Taira K J Control Release; 1998 Apr; 53(1-3):159-73. PubMed ID: 9741924 [TBL] [Abstract][Full Text] [Related]
14. A new class of RNA-binding oligomers: peptoid amide and ester analogues. Kesavan V; Tamilarasu N; Cao H; Rana TM Bioconjug Chem; 2002; 13(6):1171-5. PubMed ID: 12440849 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of HIV-1 Tat-TAR interaction by diphenylfuran derivatives: effects of the terminal basic side chains. Gelus N; Bailly C; Hamy F; Klimkait T; Wilson WD; Boykin DW Bioorg Med Chem; 1999 Jun; 7(6):1089-96. PubMed ID: 10428378 [TBL] [Abstract][Full Text] [Related]
17. Rational design of inhibitors of HIV-1 TAR RNA through the stabilisation of electrostatic "hot spots". Davis B; Afshar M; Varani G; Murchie AI; Karn J; Lentzen G; Drysdale M; Bower J; Potter AJ; Starkey ID; Swarbrick T; Aboul-ela F J Mol Biol; 2004 Feb; 336(2):343-56. PubMed ID: 14757049 [TBL] [Abstract][Full Text] [Related]
18. Simultaneously inhibition of HIV and HBV replication through a dual small interfering RNA expression system. Wu K; Mu Y; Hu J; Lu L; Zhang X; Yang Y; Li Y; Liu F; Song D; Zhu Y; Wu J Antiviral Res; 2007 May; 74(2):142-9. PubMed ID: 17173982 [TBL] [Abstract][Full Text] [Related]
19. HIV-1 inactivation by nucleic acid aptamers. Held DM; Kissel JD; Patterson JT; Nickens DG; Burke DH Front Biosci; 2006 Jan; 11():89-112. PubMed ID: 16146716 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of HIV derived lentiviral production by TAR RNA binding domain of TAT protein. Mi MY; Zhang J; He Y Retrovirology; 2005 Nov; 2():71. PubMed ID: 16293193 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]